Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Banque Nationale de Belgique | BNB | May 27, 2024 | 480.00 | +1.48 |
Barco NV | BAR | May 27, 2024 | 13.00 | -0.54 |
Basilix | BAS | May 27, 2024 | 11.40 | 0.00 |
Beaulieu Av Certificates | BEAB | May 27, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | May 27, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | May 27, 2024 | 3 984.87 | +0.38 |
Belreca - Belgian Resources and Capital Company | BELR | May 27, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | May 27, 2024 | 1.08 | 0.00 |
Belysse Group N.V. | BELYS | May 27, 2024 | 0.84 | -3.98 |
Biocartis Group NV | BCART | May 27, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | May 27, 2024 | 0.03 | 0.00 |
Biotalys | BTLS | May 27, 2024 | 3.00 | +1.35 |
Boeing | BOEI | May 27, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | May 27, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | May 27, 2024 | 3.38 | +2.27 |
Brederode S.A. | BREB | May 27, 2024 | 115.00 | -0.69 |
Campine nv | CAMB | May 27, 2024 | 83.50 | +1.83 |
Candela Invest | CAND | May 27, 2024 | 2.52 | -10.00 |
Care Property Invest NV/SA | CPINV | May 27, 2024 | 14.68 | -0.68 |
Celyad Oncology SA | CYAD | May 27, 2024 | 0.30 | 0.00 |
Cenergy Holdings | CENER | May 27, 2024 | 8.59 | -3.27 |
Chevron | CHTEX | May 27, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | May 27, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | May 27, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | May 27, 2024 | 60.35 | +0.75 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | May 27, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | May 27, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | May 27, 2024 | 46.12 | -0.17 |
Compagnie du Bois Sauvage S.A. | COMB | May 27, 2024 | 276.00 | +1.47 |
Compagnie d`Entreprises CFE SA | CFEB | May 27, 2024 | 7.52 | -0.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.